Efficacy of Rituximab for Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis in Indonesian National Referral Hospital

被引：0
|
作者：
Siregar, Desmita [1 ]
Estiasari, Riwanti [2 ]
Imran, Darma [2 ]
Maharani, Kartika [2 ]
机构：
[1] Univ Indonesia, Dept Neurol, Fac Med, Depok, Indonesia
[2] Dr Cipto Mangukusumo Hosp, Jakarta, Indonesia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-56
引用
收藏
页码：NP22 / NP22
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Rituximab in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
    Ongphichetmetha, Tatchaporn
    Jitprapaikulsan, Jiraporn
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (09) : NP3 - NP4
  • [2] Efficacy and safety of rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder
    Tatchaporn Ongphichetmetha
    Jiraporn Jitprapaikulsan
    Sasitorn Siritho
    Natthapon Rattanathamsakul
    Thammachet Detweeratham
    Naraporn Prayoonwiwat
    Scientific Reports, 14
  • [3] Efficacy and safety of rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder
    Ongphichetmetha, Tatchaporn
    Jitprapaikulsan, Jiraporn
    Siritho, Sasitorn
    Rattanathamsakul, Natthapon
    Detweeratham, Thammachet
    Prayoonwiwat, Naraporn
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [4] Pruritus in neuromyelitis optica spectrum disorders and multiple sclerosis
    He, Mianwang
    Wu, Lei
    Huang, Dehui
    Yau, Vicky
    Yu, Shengyuan
    JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 79 : 108 - 112
  • [5] Pain in multiple sclerosis and neuromyelitis optica spectrum disorders
    Pellkofer, Hannah L.
    Kumpfel, Tania
    SCHMERZ, 2021, 35 (03): : 211 - 222
  • [6] Investigation of biomarkers in multiple sclerosis and neuromyelitis optica spectrum disorders
    Arslan, B.
    Arslan, G.
    Dincel, A.
    Karabudak, R.
    Tuncer, A.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 165 - 166
  • [7] Influences of pregnancy on neuromyelitis optica spectrum disorders and multiple sclerosis
    Tong, Yanping
    Liu, Jie
    Yang, Tao
    Kang, Yuezhi
    Wang, Jingwen
    Zhao, Tianyou
    Cheng, Cuicui
    Fan, Yongping
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 25 : 61 - 65
  • [8] Treatment Options in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
    Rommer, Paulus
    Zettl, Uwe K.
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (06) : 428 - 436
  • [9] Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders
    Novi, Giovanni
    Bovis, Francesca
    Capobianco, Marco
    Frau, Jessica
    Mataluni, Giorgia
    Curti, Erica
    Zuliani, Luigi
    Cavalla, Paola
    Brambilla, Laura
    Annovazzi, Pietro
    Repice, Anna Maria
    Lanzillo, Roberta
    Esposito, Sabrina
    Benedetti, Luana
    Maietta, Ilaria
    Sica, Francesco
    Buttari, Fabio
    Malucchi, Simona
    Fenu, Giuseppe
    Landi, Doriana
    Bosa, Chiara
    Realmuto, Sabrina
    Malentacchi, Maria
    Granella, Franco
    Signori, Alessio
    Bonavita, Simona
    Uccelli, Antonio
    Sormani, Maria Pia
    Nozzolillo, Agostino
    Gallo, Fabio
    Signoriello, Elisabetta
    Clerici, Valentina Torri
    La Gioia, Sara
    Cocco, Eleonora
    Sartori, Arianna
    Rasia, Sarah
    Cordioli, Cinzia
    Barone, Stefania
    Solaro, Claudio
    Nociti, Viviana
    Gobbi, Claudio
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 36
  • [10] A meta-analysis on efficacy and safety of rituximab for neuromyelitis optica spectrum disorders
    Dong, Gu-Yi
    Meng, Yan-Hong
    Xiao, Xiang-Jian
    MEDICINE, 2022, 101 (36) : E30347
12345